Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 62,698,312
  • Shares Outstanding, K 257,150
  • Annual Sales, $ 4,163 M
  • Annual Income, $ 1,177 M
  • 60-Month Beta 1.45
  • Price/Sales 14.83
  • Price/Cash Flow 76.11
  • Price/Book 10.15

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 1.52
  • Number of Estimates 8
  • High Estimate 1.77
  • Low Estimate 1.29
  • Prior Year 0.85
  • Growth Rate Est. (year over year) +78.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
223.01 +9.33%
on 01/31/20
249.00 -2.08%
on 02/11/20
+14.07 (+6.12%)
since 01/14/20
3-Month
205.01 +18.93%
on 11/15/19
249.00 -2.08%
on 02/11/20
+38.82 (+18.94%)
since 11/14/19
52-Week
163.68 +48.96%
on 04/18/19
249.00 -2.08%
on 02/11/20
+58.10 (+31.28%)
since 02/14/19

Most Recent Stories

More News
What's in Store for Vertex in 2020 After a Remarkable 2019?

In 2020, Vertex's (VRTX) sales are expected to be primarily driven by Trikafta and higher international revenues.

REGN : 399.55 (+0.19%)
MRNA : 19.00 (-0.24%)
VRTX : 243.82 (+1.55%)
CRSP : 55.80 (-3.99%)
AstraZeneca's (AZN) Q4 Earnings and Sales Miss Estimates

AstraZeneca (AZN) misses estimates for earnings and sales. However, new drugs, mainly cancer medicines, continue to drive product sales higher.

AZN : 47.85 (-3.00%)
MRK : 82.65 (+0.83%)
NVS : 97.63 (-0.14%)
VRTX : 243.82 (+1.55%)
Pfizer's Xtandi Improves OS Rate in Prostate Cancer Study

Pfizer's (PFE) Xtandi demonstrates a significant improvement in overall survival in the late-stage PROSPER study that evaluated the drug in men with non-metastatic castration-resistant prostate cancer....

JNJ : 150.13 (+0.03%)
PFE : 36.51 (-1.14%)
NVS : 97.63 (-0.14%)
VRTX : 243.82 (+1.55%)
Zacks.com featured highlights include: Chipotle Mexican Grill, Vertex Pharmaceuticals, ResMed, Spirit Airlines and OneMain

Zacks.com featured highlights include: Chipotle Mexican Grill, Vertex Pharmaceuticals, ResMed, Spirit Airlines and OneMain

RMD : 176.60 (+0.98%)
CMG : 921.94 (+0.98%)
VRTX : 243.82 (+1.55%)
SAVE : 43.88 (-1.57%)
OMF : 47.91 (+1.96%)
Buy These 5 Stocks With Attractive Sales Growth Right Now

Sales growth is an important metric for any company, as it is a vital part of growth projections and instrumental in strategic decision making.

RMD : 176.60 (+0.98%)
CMG : 921.94 (+0.98%)
VRTX : 243.82 (+1.55%)
SAVE : 43.88 (-1.57%)
OMF : 47.91 (+1.96%)
Vertex Pharm Has Returned 35.8% Since SmarTrend Recommendation (VRTX)

SmarTrend identified an Uptrend for Vertex Pharm (NASDAQ:VRTX) on October 17th, 2019 at $178.54. In approximately 4 months, Vertex Pharm has returned 35.78% as of today's recent price of $242.43.

VRTX : 243.82 (+1.55%)
Momentum ETFs & Stocks to Buy on Renewed Market Rally

Momentum investing would be a winning strategy for those seeking higher returns in a short spell. This is because the strategy seeks to capitalize on the continuance of an existing market trend.

WDC : 69.25 (-0.47%)
PHM : 46.69 (unch)
MTUM : 136.87 (+0.68%)
PDP : 69.94 (+0.56%)
ONEO : 79.74 (-0.08%)
DWAS : 58.64 (-0.08%)
VRTX : 243.82 (+1.55%)
CMG : 921.94 (+0.98%)
UBER : 39.66 (-1.07%)
XMMO : 65.10 (+0.31%)
3 Reasons Growth Investors Will Love Vertex (VRTX)

Vertex (VRTX) possesses solid growth attributes, which could help it handily outperform the market.

VRTX : 243.82 (+1.55%)
Why Vertex (VRTX) Might be Well Poised for a Surge

Vertex (VRTX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

VRTX : 243.82 (+1.55%)
Vertex Pharm Set to Possibly Pullback After Yesterday's Rally of 1.19%

Vertex Pharm (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $240.00 to a high of $242.78. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of...

VRTX : 243.82 (+1.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade VRTX with:

Business Summary

Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs...

See More

Key Turning Points

2nd Resistance Point 248.17
1st Resistance Point 246.00
Last Price 243.82
1st Support Level 240.10
2nd Support Level 236.37

See More

52-Week High 249.00
Last Price 243.82
Fibonacci 61.8% 216.41
Fibonacci 50% 206.34
Fibonacci 38.2% 196.27
52-Week Low 163.68

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar